This Week in Aesthetics: February 1-5

February 5, 2021
Katie Hobbins

This week in aesthetics, we highlight the approval of Restylane Defyne for chin augmentation, Dr. Deborah L. Benzil’s keynote address at the 2021 Women in Cosmetic Surgery event, and more.

This week in aesthetics, Dr. Deborah L. Benzil discusses her keynote address at the upcoming second annual Women in Cosmetic Surgery event, Soliton announces the FDA clearance for its RAP device for cellulite, AAFPRS’s 2020 member survey highlights the pandemics effects on aesthetic trends, Galderma announces Restylane Defyne’s approval for chin augmentation, and Dr. Whitney Bowe explains the link between hyaluronic acid filler and potential COVID-19 vaccine reactions.

AACS WICS Event Speaker Talks Keynote Address

Dr. Deborah L. Benzil discusses her keynote address at AACS’s upcoming second annual Women in Cosmetic Surgery event, and uplifting women in medicine.

FDA Clears Soliton’s RAP Device for Cellulite

Soliton announces FDA clearance for its Rapid Acoustic Pulse (RAP) device for short-term improvement in the appearance of cellulite.

AAFPRS Member Survey Shows Pandemic Effects on Aesthetic Trends
AAFPRS’s 2020 member survey examines the effect of COVID-19 on aesthetic trends, including an increase in surgical procedures, blepharoplasty, and rhinoplasty.

Restylane Defyne Approved for Chin Augmentation

Galderma announces the FDA-approval of HA dermal filler, Restylane Defyne for use in chin augmentation.

HA Filler and COVID-19 Vaccine Reactions: What to Know

Dr. Whitney Bowe explains the link between hyaluronic acid filler and potential COVID-19 vaccine reactions, plus pearls for injectors on how to best keep patients safe.